Christopher Grant Doughty
CIK: 0002074223
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CBIO
CRESCENT BIOPHARMA, INC.
Officer
Discretionary Trading P&L
Holdings
About Doughty Christopher Grant
Doughty Christopher Grant (SEC CIK 0002074223) files insider reports with the SEC as Chief Business Officer of CRESCENT BIOPHARMA, INC. (CBIO).
Signal8 holds 2 ownership filings by Doughty Christopher Grant (1 Form 3, 1 Form 4), filed between Jun 23, 2025 and Dec 17, 2025. Those filings report 2 transactions, the latest on Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Doughty Christopher Grant's filings is in WALTHAM, MA.
Recent filings by Doughty Christopher Grant
- Dec 15, 2025: Grants or awards of CBIO shares (2 lines, Form 4, code A).
Other insiders filing for CRESCENT BIOPHARMA, INC. (CBIO)
- Lynch Ryan
- Pinkas Jan, Chief Scientific Officer
- Im Ellie Eunkyung, Chief Medical Officer
- Scalzo Richard William, Chief Financial Officer
- Bispham Barbara Harlin
- Brumm Joshua T, Chief Executive Officer